Instead, ligand/receptor analyses suggest that increased PDGFA and FGF13 expression by ICC/IDC cancer cells (cluster 6) may impact CAF phenotypes through PDGFRα and FGFR1 in fibroblasts (cluster 20)55 (Fig. 5c, d). This evidence concerns the gene FGF13 and intrahepatic cholangiocarcinoma.